Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Widdowson

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
Journal of Medical Microbiology|November 1, 1974
The antibody respones in man to infection with different serotypes of group-A streptococciJ P Widdowson, W R Maxted, C M Notley, et al.
Journal of Biomedical Materials Research. Part B, Applied Biomaterials|July 26, 2017
In vivo comparison of jellyfish and bovine collagen sponges as prototype medical devicesJonathan P Widdowson, Alex J Picton, Valerie Vince, et al.
Journal of Medical Microbiology|February 1, 1973
The use of the serum opacity reaction in the typing of group-A streptococciW R Maxted, J P Widdowson, C A Fraser, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 1, 1994
Multiple alpha-2 adrenergic receptor subtypes. II. Evidence for a role of rat R alpha-2A adrenergic receptors in the control of nociception, motor behavior and hippocampal synthesis of noradrenalineM J Millan, K Bervoets, J M Rivet, et al.
European Journal of Pharmacology|January 5, 1993
S 15535: a highly selective benzodioxopiperazine 5-HT1A receptor ligand which acts as an agonist and an antagonist at presynaptic and postsynaptic sites respectivelyM J Millan, J M Rivet, H Canton, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 1, 1994
Novel benzodioxopiperazines acting as antagonists at postsynaptic 5-HT1A receptors and as agonists at 5-HT1A autoreceptors: a comparative pharmacological characterization with proposed 5-HT1A antagonistsM J Millan, H Canton, A Gobert, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 1, 1995
S 16118 (p-guanidobenzoyl-[Hyp3,Thi5,D-Tic7,Oic8]bradykinin) is a potent and long-acting bradykinin B2 receptor antagonist, in vitro and in vivoM Félétou, P Robineau, M Lonchampt, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Journal of Medical Microbiology|November 1, 1974
The antibody respones in man to infection with different serotypes of group-A streptococciJ P Widdowson, W R Maxted, C M Notley, et al.
Journal of Biomedical Materials Research. Part B, Applied Biomaterials|July 26, 2017
In vivo comparison of jellyfish and bovine collagen sponges as prototype medical devicesJonathan P Widdowson, Alex J Picton, Valerie Vince, et al.
Journal of Medical Microbiology|February 1, 1973
The use of the serum opacity reaction in the typing of group-A streptococciW R Maxted, J P Widdowson, C A Fraser, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 1, 1994
Multiple alpha-2 adrenergic receptor subtypes. II. Evidence for a role of rat R alpha-2A adrenergic receptors in the control of nociception, motor behavior and hippocampal synthesis of noradrenalineM J Millan, K Bervoets, J M Rivet, et al.
European Journal of Pharmacology|January 5, 1993
S 15535: a highly selective benzodioxopiperazine 5-HT1A receptor ligand which acts as an agonist and an antagonist at presynaptic and postsynaptic sites respectivelyM J Millan, J M Rivet, H Canton, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 1, 1994
Novel benzodioxopiperazines acting as antagonists at postsynaptic 5-HT1A receptors and as agonists at 5-HT1A autoreceptors: a comparative pharmacological characterization with proposed 5-HT1A antagonistsM J Millan, H Canton, A Gobert, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 1, 1995
S 16118 (p-guanidobenzoyl-[Hyp3,Thi5,D-Tic7,Oic8]bradykinin) is a potent and long-acting bradykinin B2 receptor antagonist, in vitro and in vivoM Félétou, P Robineau, M Lonchampt, et al.
Pageof 4